Practical Considerations for Recognizing, Diagnosing, and Managing Non-Cystic Fibrosis Bronchiectasis: A Care Team Forum®
Program Overview
The goal of this activity is to raise awareness of and educate on the diagnostic testing and multifaceted management essential for patients with NCFBE. Clinicians will learn about the important role of neutrophil serine proteases (NSPs) in NCFBE pathophysiology, including emerging therapies that target neutrophilic inflammation. An experienced patient with NCFBE shares her difficult diagnostic and therapeutic journey and provides impactful insights for clinical care.
This activity is intended for pulmonary, infectious diseases, radiology, and primary care clinicians who manage patients with non-cystic fibrosis bronchiectasis (NCFBE).
Educational Objectives
Upon completion of this activity, participants should be better able to:
Apply current criteria for diagnosing non-cystic fibrosis bronchiectasis (NCFBE)
Employ current management strategies for the treatment of patients with NCFBE
Examine the role of neutrophil serine proteases (NSPs) in the pathophysiology of NCFBE
Assess the potential impact of emerging therapies targeting NSPs on the treatment of NCFBE
Activity Faculty
Doreen J. Addrizzo-Harris, MD (Chair)
Professor, Medicine Associate Director, Clinical and Academic Affairs Director, NYU Bronchiectasis/NTM Program
NYU Grossman School of Medicine
New York, NY
Charles L. Daley, MD
Chief, Division of Mycobacterial & Respiratory Infections
Professor, Medicine
National Jewish Health
Denver, CO
Anne E. O’Donnell, MD
Professor, Medicine Chief, Division of Pulmonary, Critical Care and Sleep Medicine
The Nehemiah and Naomi Cohen Chair in Pulmonary Disease Research
Georgetown University Medical Center
Washington, DC